PROMPERÚ
5.2.2016 14:03:43 CET | Business Wire | Press release
Today is the last day of Fruit Logistica, one of the largest events for fresh produce in the world. Just like yesterday, the Peruvian pavilion has been busy with interested buyers and importers coming to meet with Peruvian exporters. The Peruvian delegation, led by Director of Exports Promotion Luis Torres, has travelled with about 300 representatives from producers, transport and logistics, operations, agro industrial guilds, cold chain suppliers and universities.
This afternoon, the fair’s top authorities arrived at the pavilion along with Mr. Rainer Bomba, the German Vice Minister of Transport. They met with the team from Promperú to discuss the German Logistics Alliance and how this can help exporters connect with German partners to increase commerce between the two countries.
Magali Silva, Minister of Foreign Trade and Tourism (Mincetur) and President of the Board of Promperú commented: “This fair allows us to position our country’s exportable supply of fresh produce on the European market and consolidate our presence as a leading supply country. So far, it has been a huge success with many commercial and strategic meetings”. About 30% of the exhibiting companies are doing so for the first time this year and others for the 8th time, having exhibited here in the initial stages of Peru’s presence at this Fair in 2003. Their continued growth and participation in this fair is a testament to the success of Promperu’s role in driving agricultural SMEs to international markets.
For this event, Promperú has invested in a 515m2 pavilion; designed to give ample space for exporters to meet and negotiate with buyers and other interested parties. The country’s main attractions: organic bananas, blueberries, grapes, avocado, ginger and mandarins. Ms. Ana Maria Deustua, from the Peruvian Association of Agrarian Producers Guilds said: “Peru is now an important player in the world food industry and this can be seen in the development of an efficient and modern agro industrial sector that can offer quality, freshness and good taste all year round”. Certainly, this is reflected in the great interest from European importers and distributors as well as the sales data. Despite a world economic deceleration this year, Peruvian fruit and vegetable exports grew by 24%, exceeding USD 2.3 billion in 2015.
Source: PROMPERÚ (http://www.promperu.gob.pe/ )
View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005339/en/
Contact:
Branding Latin America for Promperú
Juan Francisco Gamarra
juanfrancisco@brandinglatinamerica.com
http://www.promperu.gob.pe
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom